Service description
PreveCol® Service is designed to identify the possible presence of colorectal cancer or pre-cancerous lesions (advanced adenomas) from a blood sample.
By means of this service, through a blood sample, the analysis of a series of biomarkers will be carried out, which will allow you to have a results report, with a positive or negative result on the possible presence or absence of colorectal cancer and/or precancerous lesions at the time of the test.
PreveCol® Service is intended for medium-risk individuals, of either sex, aged between 50 and 75 years (inclusive), who represent the population profile for which it has been clinically validated.
Recommendation
PreveCol® Service is recommended for medium-risk people of either sex, aged between 50 and 75 years (both inclusive).
If you have any of the following pathologies, we recommend that you consult your doctor about the suitability of the PreveCol® Service:
- Inflammatory bowel disease such as Crohn’s disease or ulcerative colitis.
- Personal history of colorectal cancer or colorectal polyps.
- Family history (two or more first-degree members, parents and children) of colorectal cancer or colorectal polyps.
- Syndromes of genetic origin such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colorectal cancer (Lynch syndrome).
- Currently, there is no clinical data available on users outside the age range (50 to 75 years) and/or who suffer from any of the pathologies mentioned above, so it is not recommended that they access the service.